Effects of Discharge Readiness on Success Following Discharge From Sub-Acute Rehab

September 17, 2019 updated by: Nancy Williams, Stony Brook University

The Effects of Discharge Readiness on Success Following Discharge From Sub-Acute Rehab

Study's purpose is to determine if a patient's perception of readiness for discharge from sub-acute rehabilitation, as measured by Readiness For Hospital Discharge Scale Patient Self-Reports Form, correlates with the patient's success after discharge, measured by patient reported number of falls, emergency room visits and hospitalizations 30 days post discharge.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

All sub-acute rehabilitation patients will be approached for study participation one day prior to discharge day from the facility. Patients will be approached in their private room within the facility to obtain consent. Consent will be reviewed with patient by investigators. Patients will be asked to demonstrate understanding of the study and what consent will imply utilizing the teach back method. If patient is able to demonstrate understanding and gives consent the MoCA will be administered. If MoCA scores falls between 22-30 they will be included in study. If MoCA score falls below 22 they will not be included in study and that will be explained to them at that time. MoCA scores will be included in patient medical record. Patient name and assigned ID number, phone number, second contact and consent will be recorded on the confidential roster sheet and stored in a locked file cabinet located in director's office at Peconic Landing. The day of discharge patients will complete the RHDS survey. Investigators will complete the study data sheet including ID number, MoCA score, RHDS score, length of stay, discharge date, and recommended discharge therapy- home care, outpatient, none. Thirty to thirty-seven days after discharge investigators will call patient and ask 3 questions from scripted form. "How many falls have you had since discharge home:, "How many visits to the emergency room have you had since your discharge home","How many admissions to the hospital have you had since your discharge home." Following completion of telephone questions, confidential roster sheet and consent form will be shredded.

Study Type

Observational

Enrollment (Anticipated)

85

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Greenport, New York, United States, 11944
        • Peconic Landing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Older adults discharged from a sub-acute rehabilitation facility

Description

Inclusion Criteria:

Montreal Cognitive Assessment score 22 or greater

  • consent with observed teach back confirmation
  • discharge from sub-acute rehabilitation

Exclusion Criteria:

  • Montreal Cognitive Assessment score less than 22
  • inability to "teach back" during consent process
  • non english speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of falls, ER visits, hospitalization
Time Frame: 30 days
Participant reported 30 days after discharge from rehabilitation facility
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 13, 2019

Primary Completion (ANTICIPATED)

June 30, 2020

Study Completion (ANTICIPATED)

December 31, 2020

Study Registration Dates

First Submitted

June 14, 2019

First Submitted That Met QC Criteria

July 5, 2019

First Posted (ACTUAL)

July 8, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 18, 2019

Last Update Submitted That Met QC Criteria

September 17, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1352630-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data Collection sheet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Questionnaire

Subscribe